Michael Czapka, MD, is an infectious disease doctor who specializes in treating and preventing infections in immunocompromised adults. Dr. Czapka provides care for people before and after organ transplants, chemotherapy, stem cell transplants and CAR T-cell therapy, with particular expertise managing fungal and viral infections.
Along with his dedication to his patients, Dr. Czapka is actively involved in clinical trials for new drugs and vaccines targeted to difficult-to-treat infections, including fungi and viruses. He also studies infections in CAR T-cell recipients and leads quality improvement initiatives at the hospital. Additionally, Dr. Czapka serves on the institutional ethics review board for clinical research and assists with board exam development within his specialty.
Infectious complications of car T-cell therapy: A longitudinal risk model.
Infectious complications of car T-cell therapy: A longitudinal risk model. Transpl Infect Dis. 2023 Nov; 25 Suppl 1:e14148.
PMID: 37695203
Phlegmonous gastritis: Evolving from surgical to medical disease.
Phlegmonous gastritis: Evolving from surgical to medical disease. IDCases. 2023; 32:e01777.
PMID: 37159573
Make Sure You Have a Safety Net: Updates in the Prevention and Management of Infectious Complications in Stem Cell Transplant Recipients.
Make Sure You Have a Safety Net: Updates in the Prevention and Management of Infectious Complications in Stem Cell Transplant Recipients. J Clin Med. 2020 Mar 21; 9(3).
PMID: 32245201
Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome.
Urine trouble: genitourinary tuberculosis and subsequent DRESS syndrome. BMJ Case Rep. 2017 Aug 07; 2017.
PMID: 28784884